Global Over the Counter (OTC) Drugs & Dietary Supplements Market Insights and Forecast to 2026

Publisher Name :
Date: 04-Aug-2020
No. of pages: 151
Inquire Before Buying

Over the Counter (OTC) Drugs & Dietary Supplements market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Over the Counter (OTC) Drugs & Dietary Supplements market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Over the Counter (OTC) Drugs & Dietary Supplements market is segmented into

- Analgesic & pain relievers

- Dermatological products

- Cough, cold, and flu products

- Vitamin supplements

- Mineral Supplements

- Ophthalmic Products

Segment by Application, the Over the Counter (OTC) Drugs & Dietary Supplements market is segmented into

- Pharmacies

- Grocery Stores

- Vitamin

- Health Food Stores

- Online Pharmacies

Regional and Country-level Analysis

The Over the Counter (OTC) Drugs & Dietary Supplements market is analysed and market size information is provided by regions (countries).

The key regions covered in the Over the Counter (OTC) Drugs & Dietary Supplements market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Over the Counter (OTC) Drugs & Dietary Supplements Market Share Analysis

Over the Counter (OTC) Drugs & Dietary Supplements market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Over the Counter (OTC) Drugs & Dietary Supplements business, the date to enter into the Over the Counter (OTC) Drugs & Dietary Supplements market, Over the Counter (OTC) Drugs & Dietary Supplements product introduction, recent developments, etc.

The major vendors covered:

- Pfizer Inc.

- Novartis International AG

- Roche Holding AG

- Merck & Co., Inc.

- Sanofi S.A

- Johnson & Johnson

- Gilead Sciences

- GlaxoSmithKline plc.

- Bayer Healthcare AG

- AstraZeneca plc.

- Alacer Corp.

- Alcon Inc.

- Alfresa Pharma Corporation

- Alkalon A/S

- Alliance Healthcare

- Allergan, Plc.

- Reckitt Benckiser Plc.

- Bausch & Lomb

- AbbVie Inc.

- The Colgate-Palmolive Company

Global Over the Counter (OTC) Drugs & Dietary Supplements Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Over the Counter (OTC) Drugs & Dietary Supplements Product Introduction
1.2 Market Segments
1.3 Key Over the Counter (OTC) Drugs & Dietary Supplements Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Type
1.4.2 Analgesic & pain relievers
1.4.3 Dermatological products
1.4.4 Cough, cold, and flu products
1.4.5 Vitamin supplements
1.4.6 Mineral Supplements
1.4.7 Ophthalmic Products
1.5 Market by Application
1.5.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Application
1.5.2 Pharmacies
1.5.3 Grocery Stores
1.5.4 Vitamin
1.5.5 Health Food Stores
1.5.6 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size, Estimates and Forecasts
2.1.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue 2015-2026
2.1.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales 2015-2026
2.2 Global Over the Counter (OTC) Drugs & Dietary Supplements, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Over the Counter (OTC) Drugs & Dietary Supplements Competitor Landscape by Players
3.1 Over the Counter (OTC) Drugs & Dietary Supplements Sales by Manufacturers
3.1.1 Over the Counter (OTC) Drugs & Dietary Supplements Sales by Manufacturers (2015-2020)
3.1.2 Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Manufacturers (2015-2020)
3.2 Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Manufacturers
3.2.1 Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Manufacturers (2015-2020)
3.2.2 Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Over the Counter (OTC) Drugs & Dietary Supplements Revenue in 2019
3.2.5 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Over the Counter (OTC) Drugs & Dietary Supplements Price by Manufacturers
3.4 Over the Counter (OTC) Drugs & Dietary Supplements Manufacturing Base Distribution, Product Types
3.4.1 Over the Counter (OTC) Drugs & Dietary Supplements Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Over the Counter (OTC) Drugs & Dietary Supplements Product Type
3.4.3 Date of International Manufacturers Enter into Over the Counter (OTC) Drugs & Dietary Supplements Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2015-2020)
4.1.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales by Type (2015-2020)
4.1.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type (2015-2020)
4.1.3 Over the Counter (OTC) Drugs & Dietary Supplements Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast by Type (2021-2026)
4.2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast by Type (2021-2026)
4.2.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast by Type (2021-2026)
4.2.3 Over the Counter (OTC) Drugs & Dietary Supplements Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2015-2020)
5.1.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales by Application (2015-2020)
5.1.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application (2015-2020)
5.1.3 Over the Counter (OTC) Drugs & Dietary Supplements Price by Application (2015-2020)
5.2 Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast by Application (2021-2026)
5.2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast by Application (2021-2026)
5.2.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast by Application (2021-2026)
5.2.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Price Forecast by Application (2021-2026)
6 North America
6.1 North America Over the Counter (OTC) Drugs & Dietary Supplements by Country
6.1.1 North America Over the Counter (OTC) Drugs & Dietary Supplements Sales by Country
6.1.2 North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Type
6.3 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Application
7 Europe
7.1 Europe Over the Counter (OTC) Drugs & Dietary Supplements by Country
7.1.1 Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales by Country
7.1.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Type
7.3 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements by Region
8.1.1 Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Sales by Region
8.1.2 Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Type
8.3 Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Application
9 Latin America
9.1 Latin America Over the Counter (OTC) Drugs & Dietary Supplements by Country
9.1.1 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Sales by Country
9.1.2 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Type
9.3 Central & South America Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements by Country
10.1.1 Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales by Country
10.1.2 Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Type
10.3 Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Application
11 Company Profiles
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Corporation Information
11.1.2 Pfizer Inc. Description and Business Overview
11.1.3 Pfizer Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
11.1.5 Pfizer Inc. Related Developments
11.2 Novartis International AG
11.2.1 Novartis International AG Corporation Information
11.2.2 Novartis International AG Description and Business Overview
11.2.3 Novartis International AG Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
11.2.5 Novartis International AG Related Developments
11.3 Roche Holding AG
11.3.1 Roche Holding AG Corporation Information
11.3.2 Roche Holding AG Description and Business Overview
11.3.3 Roche Holding AG Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
11.3.5 Roche Holding AG Related Developments
11.4 Merck & Co., Inc.
11.4.1 Merck & Co., Inc. Corporation Information
11.4.2 Merck & Co., Inc. Description and Business Overview
11.4.3 Merck & Co., Inc. Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
11.4.5 Merck & Co., Inc. Related Developments
11.5 Sanofi S.A
11.5.1 Sanofi S.A Corporation Information
11.5.2 Sanofi S.A Description and Business Overview
11.5.3 Sanofi S.A Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
11.5.5 Sanofi S.A Related Developments
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Corporation Information
11.6.2 Johnson & Johnson Description and Business Overview
11.6.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
11.6.5 Johnson & Johnson Related Developments
11.7 Gilead Sciences
11.7.1 Gilead Sciences Corporation Information
11.7.2 Gilead Sciences Description and Business Overview
11.7.3 Gilead Sciences Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
11.7.5 Gilead Sciences Related Developments
11.8 GlaxoSmithKline plc.
11.8.1 GlaxoSmithKline plc. Corporation Information
11.8.2 GlaxoSmithKline plc. Description and Business Overview
11.8.3 GlaxoSmithKline plc. Sales, Revenue and Gross Margin (2015-2020)
11.8.4 GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
11.8.5 GlaxoSmithKline plc. Related Developments
11.9 Bayer Healthcare AG
11.9.1 Bayer Healthcare AG Corporation Information
11.9.2 Bayer Healthcare AG Description and Business Overview
11.9.3 Bayer Healthcare AG Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
11.9.5 Bayer Healthcare AG Related Developments
11.10 AstraZeneca plc.
11.10.1 AstraZeneca plc. Corporation Information
11.10.2 AstraZeneca plc. Description and Business Overview
11.10.3 AstraZeneca plc. Sales, Revenue and Gross Margin (2015-2020)
11.10.4 AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
11.10.5 AstraZeneca plc. Related Developments
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Corporation Information
11.1.2 Pfizer Inc. Description and Business Overview
11.1.3 Pfizer Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
11.1.5 Pfizer Inc. Related Developments
11.12 Alcon Inc.
11.12.1 Alcon Inc. Corporation Information
11.12.2 Alcon Inc. Description and Business Overview
11.12.3 Alcon Inc. Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Alcon Inc. Products Offered
11.12.5 Alcon Inc. Related Developments
11.13 Alfresa Pharma Corporation
11.13.1 Alfresa Pharma Corporation Corporation Information
11.13.2 Alfresa Pharma Corporation Description and Business Overview
11.13.3 Alfresa Pharma Corporation Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Alfresa Pharma Corporation Products Offered
11.13.5 Alfresa Pharma Corporation Related Developments
11.14 Alkalon A/S
11.14.1 Alkalon A/S Corporation Information
11.14.2 Alkalon A/S Description and Business Overview
11.14.3 Alkalon A/S Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Alkalon A/S Products Offered
11.14.5 Alkalon A/S Related Developments
11.15 Alliance Healthcare
11.15.1 Alliance Healthcare Corporation Information
11.15.2 Alliance Healthcare Description and Business Overview
11.15.3 Alliance Healthcare Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Alliance Healthcare Products Offered
11.15.5 Alliance Healthcare Related Developments
11.16 Allergan, Plc.
11.16.1 Allergan, Plc. Corporation Information
11.16.2 Allergan, Plc. Description and Business Overview
11.16.3 Allergan, Plc. Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Allergan, Plc. Products Offered
11.16.5 Allergan, Plc. Related Developments
11.17 Reckitt Benckiser Plc.
11.17.1 Reckitt Benckiser Plc. Corporation Information
11.17.2 Reckitt Benckiser Plc. Description and Business Overview
11.17.3 Reckitt Benckiser Plc. Sales, Revenue and Gross Margin (2015-2020)
11.17.4 Reckitt Benckiser Plc. Products Offered
11.17.5 Reckitt Benckiser Plc. Related Developments
11.18 Bausch & Lomb
11.18.1 Bausch & Lomb Corporation Information
11.18.2 Bausch & Lomb Description and Business Overview
11.18.3 Bausch & Lomb Sales, Revenue and Gross Margin (2015-2020)
11.18.4 Bausch & Lomb Products Offered
11.18.5 Bausch & Lomb Related Developments
11.19 AbbVie Inc.
11.19.1 AbbVie Inc. Corporation Information
11.19.2 AbbVie Inc. Description and Business Overview
11.19.3 AbbVie Inc. Sales, Revenue and Gross Margin (2015-2020)
11.19.4 AbbVie Inc. Products Offered
11.19.5 AbbVie Inc. Related Developments
11.20 The Colgate-Palmolive Company
11.20.1 The Colgate-Palmolive Company Corporation Information
11.20.2 The Colgate-Palmolive Company Description and Business Overview
11.20.3 The Colgate-Palmolive Company Sales, Revenue and Gross Margin (2015-2020)
11.20.4 The Colgate-Palmolive Company Products Offered
11.20.5 The Colgate-Palmolive Company Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Over the Counter (OTC) Drugs & Dietary Supplements Market Estimates and Projections by Region
12.1.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast by Regions 2021-2026
12.1.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast by Regions 2021-2026
12.2 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast (2021-2026)
12.2.1 North America: Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast (2021-2026)
12.2.2 North America: Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast (2021-2026)
12.2.3 North America: Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast by Country (2021-2026)
12.3 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast (2021-2026)
12.3.1 Europe: Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast (2021-2026)
12.3.2 Europe: Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast (2021-2026)
12.3.3 Europe: Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast by Region (2021-2026)
12.5 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast (2021-2026)
12.5.1 Latin America: Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast (2021-2026)
12.5.2 Latin America: Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast (2021-2026)
12.5.3 Latin America: Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Over the Counter (OTC) Drugs & Dietary Supplements Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Over the Counter (OTC) Drugs & Dietary Supplements Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Over the Counter (OTC) Drugs & Dietary Supplements Market Segments
Table 2. Ranking of Global Top Over the Counter (OTC) Drugs & Dietary Supplements Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Analgesic & pain relievers
Table 5. Major Manufacturers of Dermatological products
Table 6. Major Manufacturers of Cough, cold, and flu products
Table 7. Major Manufacturers of Vitamin supplements
Table 8. Major Manufacturers of Mineral Supplements
Table 9. Major Manufacturers of Ophthalmic Products
Table 10. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Application 2020-2026 (K MT)
Table 11. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 12. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales by Regions 2015-2020 (K MT)
Table 13. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Regions (2015-2020)
Table 14. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales by Manufacturers (2015-2020) (K MT)
Table 16. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Share by Manufacturers (2015-2020)
Table 17. Global Over the Counter (OTC) Drugs & Dietary Supplements Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Over the Counter (OTC) Drugs & Dietary Supplements by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Over the Counter (OTC) Drugs & Dietary Supplements as of 2019)
Table 19. Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Over the Counter (OTC) Drugs & Dietary Supplements Price (2015-2020) (USD/MT)
Table 22. Over the Counter (OTC) Drugs & Dietary Supplements Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Over the Counter (OTC) Drugs & Dietary Supplements Product Type
Table 24. Date of International Manufacturers Enter into Over the Counter (OTC) Drugs & Dietary Supplements Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales by Type (2015-2020) (K MT)
Table 27. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Share by Type (2015-2020)
Table 28. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Type (2015-2020)
Table 30. Over the Counter (OTC) Drugs & Dietary Supplements Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 31. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales by Application (2015-2020) (K MT)
Table 32. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Share by Application (2015-2020)
Table 33. North America Over the Counter (OTC) Drugs & Dietary Supplements Sales by Country (2015-2020) (K MT)
Table 34. North America Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Country (2015-2020)
Table 35. North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2015-2020) (US$ Million)
Table 36. North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Country (2015-2020)
Table 37. North America Over the Counter (OTC) Drugs & Dietary Supplements Sales by Type (2015-2020) (K MT)
Table 38. North America Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type (2015-2020)
Table 39. North America Over the Counter (OTC) Drugs & Dietary Supplements Sales by Application (2015-2020) (K MT)
Table 40. North America Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Application (2015-2020)
Table 41. Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales by Country (2015-2020) (K MT)
Table 42. Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Country (2015-2020)
Table 43. Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2015-2020) (US$ Million)
Table 44. Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Country (2015-2020)
Table 45. Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales by Type (2015-2020) (K MT)
Table 46. Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type (2015-2020)
Table 47. Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales by Application (2015-2020) (K MT)
Table 48. Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Application (2015-2020)
Table 49. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Sales by Region (2015-2020) (K MT)
Table 50. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Region (2015-2020)
Table 51. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Region (2015-2020) (US$ Million)
Table 52. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Region (2015-2020)
Table 53. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Sales by Type (2015-2020) (K MT)
Table 54. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type (2015-2020)
Table 55. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Sales by Application (2015-2020) (K MT)
Table 56. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Application (2015-2020)
Table 57. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Sales by Country (2015-2020) (K MT)
Table 58. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Country (2015-2020)
Table 59. Latin Americaa Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2015-2020) (US$ Million)
Table 60. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Country (2015-2020)
Table 61. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Sales by Type (2015-2020) (K MT)
Table 62. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type (2015-2020)
Table 63. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Sales by Application (2015-2020) (K MT)
Table 64. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Application (2015-2020)
Table 65. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales by Country (2015-2020) (K MT)
Table 66. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Country (2015-2020)
Table 67. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2015-2020) (US$ Million)
Table 68. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Country (2015-2020)
Table 69. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales by Type (2015-2020) (K MT)
Table 70. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type (2015-2020)
Table 71. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales by Application (2015-2020) (K MT)
Table 72. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Application (2015-2020)
Table 73. Pfizer Inc. Corporation Information
Table 74. Pfizer Inc. Description and Major Businesses
Table 75. Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 76. Pfizer Inc. Product
Table 77. Pfizer Inc. Recent Development
Table 78. Novartis International AG Corporation Information
Table 79. Novartis International AG Description and Major Businesses
Table 80. Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 81. Novartis International AG Product
Table 82. Novartis International AG Recent Development
Table 83. Roche Holding AG Corporation Information
Table 84. Roche Holding AG Description and Major Businesses
Table 85. Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 86. Roche Holding AG Product
Table 87. Roche Holding AG Recent Development
Table 88. Merck & Co., Inc. Corporation Information
Table 89. Merck & Co., Inc. Description and Major Businesses
Table 90. Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 91. Merck & Co., Inc. Product
Table 92. Merck & Co., Inc. Recent Development
Table 93. Sanofi S.A Corporation Information
Table 94. Sanofi S.A Description and Major Businesses
Table 95. Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 96. Sanofi S.A Product
Table 97. Sanofi S.A Recent Development
Table 98. Johnson & Johnson Corporation Information
Table 99. Johnson & Johnson Description and Major Businesses
Table 100. Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 101. Johnson & Johnson Product
Table 102. Johnson & Johnson Recent Development
Table 103. Gilead Sciences Corporation Information
Table 104. Gilead Sciences Description and Major Businesses
Table 105. Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 106. Gilead Sciences Product
Table 107. Gilead Sciences Recent Development
Table 108. GlaxoSmithKline plc. Corporation Information
Table 109. GlaxoSmithKline plc. Description and Major Businesses
Table 110. GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 111. GlaxoSmithKline plc. Product
Table 112. GlaxoSmithKline plc. Recent Development
Table 113. Bayer Healthcare AG Corporation Information
Table 114. Bayer Healthcare AG Description and Major Businesses
Table 115. Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 116. Bayer Healthcare AG Product
Table 117. Bayer Healthcare AG Recent Development
Table 118. AstraZeneca plc. Corporation Information
Table 119. AstraZeneca plc. Description and Major Businesses
Table 120. AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 121. AstraZeneca plc. Product
Table 122. AstraZeneca plc. Recent Development
Table 123. Alacer Corp. Corporation Information
Table 124. Alacer Corp. Description and Major Businesses
Table 125. Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 126. Alacer Corp. Product
Table 127. Alacer Corp. Recent Development
Table 128. Alcon Inc. Corporation Information
Table 129. Alcon Inc. Description and Major Businesses
Table 130. Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 131. Alcon Inc. Product
Table 132. Alcon Inc. Recent Development
Table 133. Alfresa Pharma Corporation Corporation Information
Table 134. Alfresa Pharma Corporation Description and Major Businesses
Table 135. Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 136. Alfresa Pharma Corporation Product
Table 137. Alfresa Pharma Corporation Recent Development
Table 138. Alkalon A/S Corporation Information
Table 139. Alkalon A/S Description and Major Businesses
Table 140. Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 141. Alkalon A/S Product
Table 142. Alkalon A/S Recent Development
Table 143. Alliance Healthcare Corporation Information
Table 144. Alliance Healthcare Description and Major Businesses
Table 145. Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 146. Alliance Healthcare Product
Table 147. Alliance Healthcare Recent Development
Table 148. Allergan, Plc. Corporation Information
Table 149. Allergan, Plc. Description and Major Businesses
Table 150. Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 151. Allergan, Plc. Product
Table 152. Allergan, Plc. Recent Development
Table 153. Reckitt Benckiser Plc. Corporation Information
Table 154. Reckitt Benckiser Plc. Description and Major Businesses
Table 155. Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 156. Reckitt Benckiser Plc. Product
Table 157. Reckitt Benckiser Plc. Recent Development
Table 158. Bausch & Lomb Corporation Information
Table 159. Bausch & Lomb Description and Major Businesses
Table 160. Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 161. Bausch & Lomb Product
Table 162. Bausch & Lomb Recent Development
Table 163. AbbVie Inc. Corporation Information
Table 164. AbbVie Inc. Description and Major Businesses
Table 165. AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), R
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs